title: Aminoglycoside ototoxicity susceptibility in cystic fibrosis.
authors.forename: S A
authors.initials: SA
authors.lastname: Mulrennan
authors.forename: J
authors.initials: J
authors.lastname: Helm
authors.forename: R Bright
authors.initials: RB
authors.lastname: Thomas
authors.forename: M
authors.initials: M
authors.lastname: Dodd
authors.forename: A
authors.initials: A
authors.lastname: Jones
authors.forename: K
authors.initials: K
authors.lastname: Webb
mesh_terms: D000617:Aminoglycosides / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003550:Cystic Fibrosis / Q000235:genetics*; D004272:DNA, Mitochondrial / Q000235:genetics*; D005260:Female; D006316:Hearing Loss, High-Frequency / Q000139:chemically induced*; D006801:Humans; D009154:Mutation / Q000235:genetics; D011552:Pseudomonas Infections / Q000188:drug therapy; D055815:Young Adult
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004272:DNA, Mitochondrial